Cargando…
Risk Prediction Models for Kidney Cancer: A Systematic Review
CONTEXT: Early detection of kidney cancer improves survival; however, low prevalence means that population-wide screening may be inefficient. Stratification of the population into risk categories could allow for the introduction of a screening programme tailored to individuals. OBJECTIVE: This revie...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8642244/ https://www.ncbi.nlm.nih.gov/pubmed/32680829 http://dx.doi.org/10.1016/j.euf.2020.06.024 |
_version_ | 1784609652533624832 |
---|---|
author | Harrison, Hannah Thompson, Rachel E. Lin, Zhiyuan Rossi, Sabrina H. Stewart, Grant D. Griffin, Simon J. Usher-Smith, Juliet A. |
author_facet | Harrison, Hannah Thompson, Rachel E. Lin, Zhiyuan Rossi, Sabrina H. Stewart, Grant D. Griffin, Simon J. Usher-Smith, Juliet A. |
author_sort | Harrison, Hannah |
collection | PubMed |
description | CONTEXT: Early detection of kidney cancer improves survival; however, low prevalence means that population-wide screening may be inefficient. Stratification of the population into risk categories could allow for the introduction of a screening programme tailored to individuals. OBJECTIVE: This review will identify and compare published models that predict the risk of developing kidney cancer in the general population. EVIDENCE ACQUISITION: A search identified primary research reporting or validating models predicting the risk of kidney cancer in Medline and EMBASE. After screening identified studies for inclusion, we extracted data onto a standardised form. The risk models were classified using the Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis (TRIPOD) guidelines and evaluated using the PROBAST assessment tool. EVIDENCE SYNTHESIS: The search identified 15 281 articles. Sixty-two satisfied the inclusion criteria; performance measures were provided for 11 models. Some models predicted the risk of prevalent undiagnosed disease and others future incident disease. Six of the models had been validated, two using external populations. The most commonly included risk factors were age, smoking status, and body mass index. Most of the models had acceptable-to-good discrimination (area under the receiver-operating curve >0.7) in development and validation. Many models also had high specificity; however, several had low sensitivity. The highest performance was seen for the models using only biomarkers to detect kidney cancer; however, these were developed and validated in small case-control studies. CONCLUSIONS: We identified a small number of risk models that could be used to stratify the population according to the risk of kidney cancer. Most exhibit reasonable discrimination, but a few have been validated externally in population-based studies. PATIENT SUMMARY: In this review, we looked at mathematical models predicting the likelihood of an individual developing kidney cancer. We found several suitable models, using a range of risk factors (such as age and smoking) to predict the risk for individuals. Most of the models identified require further testing in the general population to confirm their usefulness. |
format | Online Article Text |
id | pubmed-8642244 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Elsevier B.V |
record_format | MEDLINE/PubMed |
spelling | pubmed-86422442021-12-09 Risk Prediction Models for Kidney Cancer: A Systematic Review Harrison, Hannah Thompson, Rachel E. Lin, Zhiyuan Rossi, Sabrina H. Stewart, Grant D. Griffin, Simon J. Usher-Smith, Juliet A. Eur Urol Focus Kidney Cancer CONTEXT: Early detection of kidney cancer improves survival; however, low prevalence means that population-wide screening may be inefficient. Stratification of the population into risk categories could allow for the introduction of a screening programme tailored to individuals. OBJECTIVE: This review will identify and compare published models that predict the risk of developing kidney cancer in the general population. EVIDENCE ACQUISITION: A search identified primary research reporting or validating models predicting the risk of kidney cancer in Medline and EMBASE. After screening identified studies for inclusion, we extracted data onto a standardised form. The risk models were classified using the Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis (TRIPOD) guidelines and evaluated using the PROBAST assessment tool. EVIDENCE SYNTHESIS: The search identified 15 281 articles. Sixty-two satisfied the inclusion criteria; performance measures were provided for 11 models. Some models predicted the risk of prevalent undiagnosed disease and others future incident disease. Six of the models had been validated, two using external populations. The most commonly included risk factors were age, smoking status, and body mass index. Most of the models had acceptable-to-good discrimination (area under the receiver-operating curve >0.7) in development and validation. Many models also had high specificity; however, several had low sensitivity. The highest performance was seen for the models using only biomarkers to detect kidney cancer; however, these were developed and validated in small case-control studies. CONCLUSIONS: We identified a small number of risk models that could be used to stratify the population according to the risk of kidney cancer. Most exhibit reasonable discrimination, but a few have been validated externally in population-based studies. PATIENT SUMMARY: In this review, we looked at mathematical models predicting the likelihood of an individual developing kidney cancer. We found several suitable models, using a range of risk factors (such as age and smoking) to predict the risk for individuals. Most of the models identified require further testing in the general population to confirm their usefulness. Elsevier B.V 2021-11 /pmc/articles/PMC8642244/ /pubmed/32680829 http://dx.doi.org/10.1016/j.euf.2020.06.024 Text en © 2020 European Association of Urology. Published by Elsevier B.V. https://creativecommons.org/licenses/by/4.0/This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Kidney Cancer Harrison, Hannah Thompson, Rachel E. Lin, Zhiyuan Rossi, Sabrina H. Stewart, Grant D. Griffin, Simon J. Usher-Smith, Juliet A. Risk Prediction Models for Kidney Cancer: A Systematic Review |
title | Risk Prediction Models for Kidney Cancer: A Systematic Review |
title_full | Risk Prediction Models for Kidney Cancer: A Systematic Review |
title_fullStr | Risk Prediction Models for Kidney Cancer: A Systematic Review |
title_full_unstemmed | Risk Prediction Models for Kidney Cancer: A Systematic Review |
title_short | Risk Prediction Models for Kidney Cancer: A Systematic Review |
title_sort | risk prediction models for kidney cancer: a systematic review |
topic | Kidney Cancer |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8642244/ https://www.ncbi.nlm.nih.gov/pubmed/32680829 http://dx.doi.org/10.1016/j.euf.2020.06.024 |
work_keys_str_mv | AT harrisonhannah riskpredictionmodelsforkidneycancerasystematicreview AT thompsonrachele riskpredictionmodelsforkidneycancerasystematicreview AT linzhiyuan riskpredictionmodelsforkidneycancerasystematicreview AT rossisabrinah riskpredictionmodelsforkidneycancerasystematicreview AT stewartgrantd riskpredictionmodelsforkidneycancerasystematicreview AT griffinsimonj riskpredictionmodelsforkidneycancerasystematicreview AT ushersmithjulieta riskpredictionmodelsforkidneycancerasystematicreview |